Cyclin B1 Antikörper (AA 1-433)
Kurzübersicht für Cyclin B1 Antikörper (AA 1-433) (ABIN514100)
Target
Alle Cyclin B1 (CCNB1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-433
-
Verwendungszweck
- Rabbit polyclonal antibody raised against a full-length human CCNB1 protein.
-
Sequenz
- MALRVTRNSK INAENKAKIN MAGAKRVPTA PAATSKPGLR PRTALGDIGN KVSEQLQAKM PMKKEAKPSA TGKVIDKKLP KPLEKVPMLV PVPVSEPVPE PEPEPEPEPV KEEKLSPEPI LVDTASPSPM ETSGCAPAEE DLCQAFSDVI LAVNDVDAED GADPNLCSEY VKDIYAYLRQ LEEEQAVRPK YLLGREVTGN MRAILIDWLV QVQMKFRLLQ ETMYMTVSII DRFMQNNCVP KKMLQLVGVT AMFIASKYEE MYPPEIGDFA FVTDNTYTKH QIRQMEMKIL RALNFGLGRP LPLHFLRRAS KIGEVDVEQH TLAKYLMELT MLDYDMVHFP PSQIAAGAFC LALKILDNGE WTPTLQHYLS YTEESLLPVM QHLAKNVVMV NQGLTKHMTV KNKYATSKHA KISTLPQLNS ALVQDLAKAV AKV
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody reactive against mammalian transfected lysate.
-
Immunogen
- CCNB1 (NP_114172.1, 1 a.a. ~ 433 a.a) full-length human protein.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma." in: Molecular & cellular proteomics : MCP, Vol. 12, Issue 5, pp. 1335-49, (2013) (PubMed).
: "
-
Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma." in: Molecular & cellular proteomics : MCP, Vol. 12, Issue 5, pp. 1335-49, (2013) (PubMed).
-
- Cyclin B1 (CCNB1)
-
Andere Bezeichnung
- CCNB1
-
Hintergrund
-
Full Gene Name: cyclin B1
Synonyms: CCNB -
Gen-ID
- 891
-
NCBI Accession
- NM_031966
-
Pathways
- Zellzyklus, AMPK Signaling, Mitotic G1-G1/S Phases, M Phase
Target
-